Editas Medicine, Inc. (EDIT)
3.00
-0.11
(-3.54%)
USD |
NASDAQ |
Aug 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine 1 Year Total Returns (Daily) : 7.14% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.14% |
| August 21, 2026 | 13.92% |
| August 20, 2026 | 10.11% |
| August 19, 2026 | 23.57% |
| August 18, 2026 | 5.49% |
| August 17, 2026 | -6.27% |
| August 14, 2026 | -4.73% |
| August 13, 2026 | -8.77% |
| August 12, 2026 | 24.02% |
| August 11, 2026 | 34.09% |
| August 10, 2026 | 27.15% |
| August 07, 2026 | 15.66% |
| August 06, 2026 | 14.62% |
| August 05, 2026 | 5.77% |
| August 04, 2026 | 8.20% |
| August 03, 2026 | 8.61% |
| July 31, 2026 | 2.79% |
| July 30, 2026 | 6.75% |
| July 29, 2026 | 0.39% |
| July 28, 2026 | -11.49% |
| July 27, 2026 | -14.92% |
| July 24, 2026 | -20.25% |
| July 23, 2026 | -21.10% |
| July 22, 2026 | -17.26% |
| July 21, 2026 | -8.25% |
| Date | Value |
|---|---|
| July 20, 2026 | 4.35% |
| July 17, 2026 | 9.16% |
| July 16, 2026 | 1.41% |
| July 15, 2026 | 10.55% |
| July 14, 2026 | 10.88% |
| July 13, 2026 | 9.72% |
| July 10, 2026 | 6.54% |
| July 09, 2026 | 7.14% |
| July 08, 2026 | 28.32% |
| July 07, 2026 | 47.64% |
| July 06, 2026 | 42.02% |
| July 02, 2026 | 42.58% |
| July 01, 2026 | 45.78% |
| June 30, 2026 | 47.27% |
| June 29, 2026 | 40.35% |
| June 26, 2026 | 34.43% |
| June 25, 2026 | 25.11% |
| June 24, 2026 | 24.44% |
| June 23, 2026 | 31.43% |
| June 22, 2026 | 26.13% |
| June 18, 2026 | 14.47% |
| June 17, 2026 | 19.16% |
| June 16, 2026 | 9.26% |
| June 15, 2026 | 24.87% |
| June 12, 2026 | 14.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Geron Corp. | 4.11% |
| Novavax, Inc. | 13.01% |
| Recursion Pharmaceuticals, Inc. | -34.21% |
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |